Literature DB >> 16554737

Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis.

Paolo Cossu-Rocca1, Shaobo Zhang, Lawrence M Roth, John N Eble, Wenxin Zheng, Fadi W Abdul Karim, Helen Michael, Robert E Emerson, Timothy D Jones, Eyas M Hattab, Liang Cheng.   

Abstract

Dysgerminoma is the most common malignant ovarian germ cell tumor and shares histological and immunophenotypical features with its testicular counterpart, seminoma. Chromosome 12p abnormalities are genetic hallmarks of testicular seminomas. Little is known about these genetic changes in dysgerminoma. We performed dual color fluorescence in situ hybridization (FISH) analyses with a centromeric alpha-satellite probe for chromosome 12 and a subtelomeric probe for 12p on paraffin-embedded tissue sections from 21 dysgerminomas and two gonadoblastomas. Chromosome 12p abnormalities were detected in 81% of dysgerminomas. In all, 57% of cases had only isochromosome 12p and 5% had only 12p overrepresentation. In all, 19% had both isochrome 12p and 12p overrepresentation. Gonadoblastomas were negative for isochromosome 12p or 12p overrepresentation. Chromosome 12p abnormalities are common in dysgerminoma of the ovary. FISH analyses for chromosome 12p abnormalities may be a useful diagnostic adjunct for confirming the diagnosis of dysgerminoma and for distinguishing it from nongerm cell malignancies that enter into the differential diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 16554737     DOI: 10.1038/modpathol.3800576

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

1.  Pure cartilaginous teratoma of the testis: an immunohistochemistry and fluorescence in situ hybridisation study.

Authors:  Ryan Des Jean; John N Eble; Shaobo Zhang; Liang Cheng
Journal:  J Clin Pathol       Date:  2007-06-29       Impact factor: 3.411

2.  Development of a risk stratification system to guide treatment for female germ cell tumors.

Authors:  Jane L Meisel; Kaitlin M Woo; Nora Sudarsan; Jana Eng; Sujata Patil; Erin P Jacobsen; Rajmohan Murali; Ginger J Gardner; George J Bosl; Carol Aghajanian; Darren R Feldman
Journal:  Gynecol Oncol       Date:  2015-06-24       Impact factor: 5.482

3.  Gonadal and extragonadal germ cell tumours in the United States, 1973-2007.

Authors:  A Stang; B Trabert; N Wentzensen; M B Cook; C Rusner; J W Oosterhuis; K A McGlynn
Journal:  Int J Androl       Date:  2012-02-09

4.  Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

Authors:  Orlandric Miree; Sanjeev Kumar Srivastava; Santanu Dasgupta; Seema Singh; Rodney Rocconi; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Low-grade epithelial ovarian cancer: what a radiologist should know.

Authors:  Sherif Elsherif; Sanaz Javadi; Chitra Viswanathan; Silvana Faria; Priya Bhosale
Journal:  Br J Radiol       Date:  2019-01-31       Impact factor: 3.039

6.  Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008.

Authors:  Carsten Rusner; Britton Trabert; Alexander Katalinic; Joachim Kieschke; Katharina Emrich; Andreas Stang
Journal:  Cancer Epidemiol       Date:  2013-05-14       Impact factor: 2.984

7.  Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation.

Authors:  Stephanie L Skala; Chia-Jen Liu; Aaron M Udager; Andrew P Sciallis
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

Review 8.  Roles of the Y chromosome genes in human cancers.

Authors:  Tatsuo Kido; Yun-Fai Chris Lau
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

9.  Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.

Authors:  C Blake Gilks
Journal:  J Oncol       Date:  2009-12-30       Impact factor: 4.375

Review 10.  Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.

Authors:  Sigrid Marie Kraggerud; Christina E Hoei-Hansen; Sharmini Alagaratnam; Rolf I Skotheim; Vera M Abeler; Ewa Rajpert-De Meyts; Ragnhild A Lothe
Journal:  Endocr Rev       Date:  2013-04-10       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.